Almuradova D.M., Ravshanova N.B., and Abdurakhimov A.I. “Clinical Outcomes of EGFR-Targeted Therapy With Erlotinib Versus Polychemotherapy in NSCLC: A Statistical Analysis”. International Journal of Medical Sciences And Clinical Research 6, no. 03 (March 31, 2026): 82–86. Accessed April 11, 2026. https://theusajournals.com/index.php/ijmscr/article/view/9783.